Dimensional Fund Advisors LP Acorda Therapeutics Inc Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.3 - $1.67 $5,925 - $32,985	-19,752 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.61 - $2.5 $39,839 - $61,862	-24,745 Reduced 55.61%	19,752 $32,000
Q4 2021 Feb 09, 2022	BUY	$2.3 - $4.71 $6,074 - $12,439	2,641 Added 6.31%	44,497 $106,000
Q3 2021 Nov 12, 2021	SELL	$3.36 - $4.79 $119,454 - $170,294	-35,552 Reduced 45.93%	41,856 $193,000
Q2 2021 Aug 12, 2021	BUY	$3.61 - $5.23 $88,611 - $128,375	24,546 Added 46.43%	77,408 $369,000
Q1 2021 May 14, 2021	BUY	$3.8 - $8.04 $200,875 - $425,010	52,862 New	52,862 $257,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.